首页> 外文期刊>Antiviral Research >Inhibition of enterovirus 71 replication by an a-hydroxy-nitrile derivative NK-1.9k
【24h】

Inhibition of enterovirus 71 replication by an a-hydroxy-nitrile derivative NK-1.9k

机译:通过羟基丁腈衍生物NK-1.9K抑制肠病毒71复制

获取原文
获取原文并翻译 | 示例
       

摘要

Enterovirus 71 (EV71) is one of the major etiological agents of human hand-foot-and-mouth disease (HFMD) worldwide. EV71 infection in young children and people with immunodeficiency causes severe symptoms with a high fatality rates. However, there is still no approved drugs to treat such infections. Based on our previous report of a peptide-aldehyde anti-EV71 protease, we present here a highly specific a-hydroxy-nitrile derivative NK-1.9k, which inhibited the proliferation of multiple EV71 strains and coxsackievirus A16 (CVA16) in various cells with EC50 of 37.0 nM with low cytotoxicity (CC50 > 200 mu M). The hydroxy-nitrile covalent warhead conferred NK-1.9k high potency and selectivity to interact with the cysteine residue of the active site of the viral protease. We also documented the resistance to NK-1.9k with a N69S mutation in EV71 3C(Pro). The combination of NK-1.9k and EV71 polymerase or entry inhibitors produced strong synergistic antiviral effects. Collectively, our findings suggest our compounds can potentially be developed as drugs for the treatment of HFMD. (C) 2017 Published by Elsevier B.V.
机译:肠道病毒71(EV71)是全球人脚口病(HFMD)的主要病因特征之一。幼儿EV71感染幼儿和免疫缺陷的人导致严重的症状具有高的死亡率。然而,仍然没有批准的药物来治疗这种感染。基于我们对肽 - 醛抗EV71蛋白酶的先前报告,我们在此存在高度特异的A-羟基 - 丁腈衍生物NK-1.9K,其在各种细胞中抑制多个EV71菌株和CoxSackeivirus A16(CVA16)的增殖EC50为37.0nm,具有低细胞毒性(CC50>200μm)。羟基腈共价弹头赋予NK-1.9K高效力和选择性与病毒蛋白酶有活性位点的半胱氨酸残基相互作用。我们还将对NK-1.9K的抗性记录在EV71 3C(Pro)中具有N69S突变。 NK-1.9K和EV71聚合酶或进入抑制剂的组合产生了强烈的协同抗病毒作用。统称,我们的研究结果表明我们的化合物可能是作为治疗HFMD治疗的药物。 (c)2017年由Elsevier B.V发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号